These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7880431)

  • 1. Clinical significance of low levels of second-trimester maternal serum human chorionic gonadotropin.
    Santolaya-Forgas J; Burd LI; Burton BK
    Fetal Diagn Ther; 1994; 9(6):362-6. PubMed ID: 7880431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol.
    Santolaya-Forgas J; Jessup J; Burd LI; Prins GS; Burton BK
    J Reprod Med; 1996 Feb; 41(2):87-90. PubMed ID: 8656420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered newborn gender distribution in patients with low mid-trimester maternal serum human chorionic gonadotropin (MShCG).
    Santolaya-Forgas J; Meyer WJ; Burton BK; Scommegna A
    J Matern Fetal Med; 1997; 6(2):111-4. PubMed ID: 9086428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: relation to fetal weight and preterm delivery.
    Morssink LP; Kornman LH; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1995 Nov; 15(11):1041-6. PubMed ID: 8606883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
    Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation between serum markers in the second trimester and placental pathology. A study on extremely small for gestational age fetuses.
    Morssink LP; de Wolf BT; Kornman LH; Beekhuis JR; van der Hall TP; Mantingh A
    Br J Obstet Gynaecol; 1996 Aug; 103(8):779-83. PubMed ID: 8760707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased maternal serum human chorionic gonadotropin concentrations are an independent risk factor for SGA in dichorionic twin gestations.
    Hershkovitz R; Bar G; Erez O; Smolin A; Sheiner E; Mishori-Dery A; Mazor M
    J Matern Fetal Neonatal Med; 2005 Aug; 18(2):117-22. PubMed ID: 16203597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein.
    Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG
    J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
    Yaron Y; Cherry M; Kramer RL; O'Brien JE; Hallak M; Johnson MP; Evans MI
    Am J Obstet Gynecol; 1999 Oct; 181(4):968-74. PubMed ID: 10521763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum triple analyte screening and adverse pregnancy outcome.
    Milunsky A; Nebiolo L
    Fetal Diagn Ther; 1996; 11(4):249-53. PubMed ID: 8823604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies.
    Lepage N; Chitayat D; Kingdom J; Huang T
    Am J Obstet Gynecol; 2003 May; 188(5):1354-9. PubMed ID: 12748511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HELLP syndrome: its association with unexplained elevation of MSAFP and MShCG in the second trimester.
    Morssink LP; Heringa MP; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1997 Jul; 17(7):601-6. PubMed ID: 9249859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
    J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
    Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
    Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome.
    Wenstrom KD; Owen J; Boots LR; DuBard MB
    Am J Obstet Gynecol; 1994 Oct; 171(4):1038-41. PubMed ID: 7524322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
    Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
    Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly.
    Celentano C; Guanciali-Franchi PE; Liberati M; Palka C; Fantasia D; Morizio E; Calabrese G; Stuppia L; Rotmensch S
    Prenat Diagn; 2005 Mar; 25(3):220-4. PubMed ID: 15791663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for adverse perinatal outcome by biomarkers in maternal serum; a comparison of elevated maternal serum alpha-fetoprotein versus human chorionic gonadotropin].
    Tanaka M; Natori M; Ishimoto H; Gohda N; Kiyokawa K; Yamauchi J; Miyazaki T; Kobayashi T; Nozawa S
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1229-33. PubMed ID: 7531210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications.
    Gonen R; Perez R; David M; Dar H; Merksamer R; Sharf M
    Obstet Gynecol; 1992 Jul; 80(1):83-6. PubMed ID: 1603504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.